Atezolizumab (Tecentriq) Tops Chemo for Platinum-ineligible NSCLC ...Middle East

Medscape - News
The checkpoint inhibitor was associated with better survival and adverse events vs single-agent chemo for advanced NSCLC. The study was published as a preprint and has not yet been peer reviewed. First Look

Hence then, the article about atezolizumab tecentriq tops chemo for platinum ineligible nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Atezolizumab (Tecentriq) Tops Chemo for Platinum-ineligible NSCLC )

Apple Storegoogle play

Last updated :

Also on site :